Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature
Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…Gerstmann-Sträussler-Scheinker disease presenting as dystonia
Objective: Gerstmann-Sträussler-Scheinker disease (GSS) is a type of human transmissible spongiform encephalopathy that is determined genetically. Background: Gerstmann-Sträussler-Scheinker disease (GSS) is a type of human…Determination of glycine transporter 1 levels with [3H]-NFPS binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia
Objective: To determine the distribution of the glycine transporter 1 (GlyT1) in brain areas implicated in parkinsonism and L-3,4-dihydroxyphenylalanine (L-DOPA) induced dyskinesia in the 6-hydroxydopamine…Women with Parkinson’s Disease (PD) and High Coffee Use Have a Shorter Time to Medication Initiation
Objective: Investigate how coffee use prior to PD diagnosis affects medication initiation in PD. Background: Population studies show a decreased incidence of PD for men…The REONPARK (REgistry of the use of COMT-inhibitors in the maNagement of patients with PARKinson’s disease in Spain who present early motor fluctuations) study: rationale and design of a national, multicentre and prospective study
Objective: To describe the real-world use of catechol-O-methyltransferase (COMT) inhibitors add on to levodopa/dopa decarboxylase inhibitor (DDCI) in patients with Parkinson’s disease (PD) suffering from…iFall: Usability of a co-produced falls reporting smartphone application in people with Parkinson’s
Objective: To assess the usability of a co-produced smartphone application for falls reporting in people with Parkinson’s (PwP) Background: Falls commonly occur in PwP, which…No association between naturally occurring plasma tau autoantibodies and movement disorders
Objective: To determine if there is an association between the presence of naturally occurring plasma tau autoantibodies and a movement disorder diagnosis. Background: The microtubule-associated…Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey
Objective: As insight in the drivers of varying symptom severity might help manage symptoms, this study investigates the association between symptom severity and contextual factors…Pain and Disability Outcomes in Hemiparetic Patients Naive to Botulinum Toxins With Upper and Lower Limb Spasticity Treated With OnabotulinumtoxinA: Insights From the ASPIRE Study
Objective: To assess measures of pain and functional impairment in patients treated with onabotulinumtoxinA (onabotA) who are naive to botulinum toxins with upper limb (UL)…Multiple system atrophy mimicked by mitochondrial disease.
Objective: Characterized a case with A3243G mutation in mtDNA tRNALeu, a variant of mitochondrial disease; MELAS, which presents with atypical parkinsonism as Multiple system atrophy.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.